| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology (M.Y., F.K., X.C., X.L., Y.K., H.S.), Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan; and Department of Endocrinology and Diabetes (M.Y., Y.O.), Nagoya University Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
Address all correspondence and requests for reprints to: Fukushi Kambe, M.D., Ph.D., Department of Endocrinology, Research Institute of Environmental Medicine (RIEM), Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. E-mail: kambe{at}riem.nagoya-u.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
or TRβ in Neuro2a cells enhanced this effect of T3, indicating the involvement of TRs. Because HeLa cells express only Ca2+/calmodulin-dependent protein kinase kinase-β (CaMKKβ), one of two known AMPK kinases, it was suggested that the effect of T3 is mediated by CaMKKβ. Indeed, experiments using a CaMKK inhibitor, STO-609, and an isoform-specific small interfering RNA demonstrated the CaMKKβ-dependent phosphorylation of AMPK. Furthermore, T3 was found to rapidly induce intracellular Ca2+ mobilization in HeLa cells, and a Ca2+ chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), suppressed T3- as well as ionomycin-dependent phosphorylation of AMPK. In addition, T3-dependent oxidation of palmitic acids was attenuated by BAPTA, STO-609, and the small interfering RNA for CaMKKβ, indicating that T3-induced activation of AMPK leads to increased fatty acid oxidation. These results demonstrate that T3 nontranscriptionally activates AMPK via intracellular Ca2+ mobilization and CaMKKβ activation, thereby stimulating mitochondrial fatty acid oxidation. | INTRODUCTION |
|---|
|
|
|---|
AMPK is a heterotrimeric complex composed of a catalytic
-subunit and regulatory β- and
-subunits and is allosterically activated by the phosphorylation of Thr-172 on the
-subunit, which is catalyzed by upstream kinases such as LKB1. Binding of AMP to the
-subunit makes AMPK a better substrate for LKB1 (3). Recently, Ca2+/calmodulin-dependent protein kinase kinase-β (CaMKKβ) was identified as another upstream kinase (4, 5, 6). Upon an elevation of intracellular Ca2+, CaMKKβ is activated and directly phosphorylates the
-subunit of AMPK at Thr-172. This action does not require intracellular AMP elevation.
The role played by AMPK in the regulation of fatty acid oxidation has been intensively studied in muscle cells (2). Activated AMPK directly phosphorylates Ser-79 in acetyl-coenzyme A (CoA) carboxylase (ACC) and down-regulates its enzymatic activity, resulting in a decrease in intracellular malonyl-CoA levels. Because malonyl-CoA inhibits fatty acid uptake into mitochondria by preventing carnitine:palmitoyl-CoA acyl transferase present on the mitochondrial membrane, its decrease allows fatty acid uptake, leading to increased fatty acid oxidation and ATP production.
The major thyroid hormone (TH) produced by the thyroid gland is L-T4 (T4), which is deiodinated to T3 in peripheral tissues. TH impacts on a number of physiological events, including growth, development, differentiation, thermogenesis, and metabolism. T3 receptor (TR) belongs to the steroid/thyroid hormone receptor superfamily and functions as a ligand-dependent transcription factor. Two separate genes, THRA and THRB, encode TR
and TRβ, respectively. Multiple isoforms are generated from each gene by alternative splicing and promoter usage. Some distinct isoforms of TR
are localized to mitochondria (7).
TH stimulates cellular oxygen consumption and is considered to be a major regulator of mitochondrial activities (8, 9). Although some controversy remains, TH increases mitochondrial oxidative phosphorylation, membrane potential (
), and uncoupling proton transport that generates heat. TH concomitantly enhances ATP production capacity as a result of increased oxidative phosphorylation (10). Although the molecular bases underlying these TH actions are still not fully understood, TH stimulates the expression of components of oxidative phosphorylation (11, 12, 13), proteins involved in uncoupling proton transport (14), and factors regulating mitochondrial activities (15). These proteins are encoded by nuclear and mitochondrial genes, and T3 modulates their expression via TRs present in the respective organelles. Furthermore, T3 stimulates mitochondrial DNA replication (8). In addition to such long-term, probably mainly transcriptional effects, TH exerts nontranscriptional, short-term effects on mitochondria. T3 rapidly increases oxygen consumption and oxidative phosphorylation in mitochondria, in a process that does not require protein synthesis (16). Several mitochondrial proteins have been shown to bind to TH with high affinity. However, their roles in the short-term effects of TH appear to be controversial (17). In the present study, we examined the possible involvement of AMPK in the stimulatory actions of T3 on mitochondria. We provide evidence that T3 rapidly activates AMPK via intracellular Ca2+ mobilization and CaMKKβ activation.
| RESULTS |
|---|
|
|
|---|
-Subunit of AMPK
-subunit of AMPK. T3 treatment further increased the phosphorylation. Similar results were obtained with thyroid follicular FRTL-5 cells, indicating that T3-induced phosphorylation of AMPK is not a phenomenon that is restricted to a particular cell type. A time-course experiment (Fig. 1B
|
and TRβ Mediate the T3-Induced Phosphorylation of AMPK
and N2aTRβ cells, which stably express TR
1 and TRβ1, respectively. As shown in Fig. 2A
-subunit of AMPK in wild-type N2a cells, but subsequent treatment with T3 had only a marginal effect. A similar tendency was observed for Ser-79 phosphorylation of ACC. By contrast, N2aTR
and N2aTRβ cells markedly responded to T3. Serum deprivation increased the phosphorylation of AMPK and ACC, and T3 further increased this phosphorylation.
|
-subunit showed that T3 significantly increased the fluorescence intensity in the cytoplasm, indicating that T3-induced phosphorylation of AMPK mainly occurred in the cytoplasm (Fig. 2B
, and N2aTRβ cells are shown in Fig. 2C
and -β isoforms can mediate the T3-induced phosphorylation of AMPK. The TR mRNA levels in N2a cells were compared with those in C2C12 and 3T3-L1 cells by RT-PCR. As shown in supplemental Fig. A (published as supplemental data on The Endocrine Societys Journals Online web site at http://mend.endojournals.org), similar levels of TR mRNA were detected in all three cell types. Thus, it is unlikely that the lower response of N2a cells to T3 is due to a difference in TR expression. Some components of the downstream signaling pathway might be less functional in N2a cells.
CaMKKβ Mediates the T3-Induced Phosphorylation of AMPK
To explore the signaling cascade underlying the T3 action, we first examined the expression of LKB1 and CaMKKβ in the cells used in this study. As shown in Fig. 3A
, RT-PCR analysis revealed that whereas CaMKKβ was expressed in all of the cell types tested, LKB1 was not expressed in HeLa cells, consistent with a previous report (6). Thus, we used HeLa cells to study whether LKB1 is required for the T3-induced phosphorylation of AMPK. TR
and TRβ1 expression was detected by RT-PCR in HeLa cells (data not shown). As shown in Fig. 3B
, T3 induced a significant increase in the phosphorylation of Thr-172 in the
-subunit of AMPK. Ser-79 phosphorylation of ACC was also increased by T3 in HeLa cells, indicating that LKB1 was dispensable for the T3 action. We then tested a CaMKK inhibitor, STO-609. Hawley et al. (4) reported that 10 µM STO-609 inhibits a broad range of kinases, but 1 µM STO-609 is relatively selective for CaMKK
and -β. As shown in Fig. 3B
, 1 µM STO-609 was sufficient to prevent the effect of T3 on AMPK and ACC, suggesting the involvement of CaMKKβ. This notion was validated by the following experiment using small interfering RNA (siRNA).
|
, and TRβ1 in HeLa cells were examined by RT-PCR (Fig. 3C
and TRβ1. A nontargeting, control siRNA had no effect on the expression of these three proteins. To confirm the silencing effect of CaMKKβ siRNA, HeLa cells were treated with a Ca2+ ionophore, ionomycin, and the levels of AMPK and ACC phosphorylation were determined. As shown in Fig. 3D
T3-Dependent Intracellular Ca2+ Mobilization Is Associated with AMPK Phosphorylation
We next studied T3-dependent intracellular Ca2+ mobilization in HeLa cells by using a fluorescent indicator, Fluo-4. As shown in Fig. 4A
, T3 induced a rapid and significant increase in intracellular Ca2+ levels, which gradually decreased after T3 withdrawal. When the cells were preincubated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), a Ca2+ chelator, the fluorescence signals from Ca2+/Fluo-4 complexes were markedly suppressed, possibly due to the competition of BAPTA with Fluo-4 to bind Ca2+. We repeated the experiment by using a ratiometric Ca2+ indicator, Indo-1 (Fig. 4B
). The profiles of Ca2+ increase were similar to those obtained with Fluo-4. The lower degree of Ca2+ increase may be due to the lower sensitivity of Indo-1. These results demonstrate the T3 induction of intracellular Ca2+ mobilization in HeLa cells.
|
|
T3-Dependent Fatty Acid Oxidation Is Mediated by CaMKKβ
The above studies showed that T3 induced Ser-79 phosphorylation of ACC via AMPK activation, which would result in ACC inactivation and increase fatty acid oxidation (2). To confirm this notion, the effects of T3 on the oxidation of labeled palmitic acids were assessed in HeLa cells. As shown in Fig. 6A
, the basal oxidation levels were significantly decreased by BAPTA, but not by STO-609, suggesting that intracellular Ca2+, but not CaMKK, might contribute to the basal fatty acid oxidation. T3 significantly increased the fatty acid oxidation. This increase was attenuated not only by BAPTA but also by STO-609. When HeLa cells transfected with CaMKKβ siRNA were subjected to the fatty acid oxidation assay, the T3-dependent increase was significantly reduced (Fig. 6B
). These results indicate that T3-dependent fatty acid oxidation is mediated by CaMKKβ in HeLa cells.
|
| DISCUSSION |
|---|
|
|
|---|
CaMKKβ was first identified as a kinase upstream of Ca2+/calmodulin-dependent protein kinase I and IV (24). Recent extensive studies involving yeast genetics have revealed that CaMKKβ can also phosphorylate AMPK in mammalian cells (4, 5, 6). These studies showed that ionomycin, hydrogen peroxide, sorbitol, and 2-deoxyglucose stimulated AMPK via CaMKKβ activation. These reagents mimic the situations of intracellular Ca2+ mobilization, oxidant stress, osmotic stress, and energy deprivation, respectively, thus suggesting that CaMKKβ-dependent AMPK activation would play an important role in cells exposed to various physiological and pathological conditions. However, the physiological stimuli activating the CaMKKβ-AMPK cascade remain poorly identified. It was recently reported that thrombin can activate this cascade in vein endothelial cells (25). Moreover, antigen receptor activation in T lymphocytes was reported to stimulate this cascade (26). T3 is another physiological stimulus activating AMPK via CaMKKβ.
T3 has been shown to nontranscriptionally modulate a variety of proteins, including ERKs, the sodium/proton exchanger, a voltage-dependent potassium channel (ether-a-go-go related gene channel), the sodium/potassium ATPase, and phosphoinositide 3 kinase (PI3K) (20, 22, 27, 28, 29). These proteins do not directly bind T3, so their functions are regulated by T3 indirectly, most likely through T3/TR complexes. The involvement of TR in the nontranscriptional effect of T3 was demonstrated in mice possessing a mutant TRβ that selectively lacks DNA-binding activity (30). Recent in vitro studies including ours have shown that TR directly interacts with a regulatory subunit of PI3K, suggesting an essential role of TR in the regulation of PI3K by T3 (19, 20, 21, 22). In addition, it was reported that T3-induced activation of Akt, a kinase downstream of PI3K, was greatly impaired in TR
and -β double-knockout mice (21). In the current study, the involvement of TR
and TRβ in the T3-induced activation of AMPK was suggested by using cells stably expressing TR
or TRβ. However, unlike the case of PI3K, T3/TR complexes would not directly contribute to AMPK activation; rather, they triggered intracellular Ca2+ mobilization.
This study demonstrates that T3 rapidly, within a minute, increases intracellular Ca2+ levels and that this is associated with the phosphorylation of AMPK and ACC. Several recent reports describe acute effects of T3 on intracellular Ca2+. DArezzo et al. (28) showed in the L-6 rat myoblast cell line that T3 induces intracellular Ca2+ mobilization within a few minutes, through activation of IP3 receptors and without contributions of extracellular Ca2+ and ryanodine receptors. Interestingly, T3-bound agarose, which cannot enter cells, reproduced this effect of T3, suggesting that its action is initiated at the plasma membrane, but the nature of T3-binding protein on the membrane was not identified. Saelim et al. (18) also reported that T3 increases the IP3-mediated Ca2+ wave period and amplitude in Xenopus oocytes expressing mitochondrial forms of TR and that this increase is mediated by mitochondrial Ca2+ uptake. They further showed that increased mitochondrial membrane potential (
) contributes to the uptake. These reports indicate that T3 induces intracellular Ca2+ mobilization by cooperatively stimulating the endoplasmic reticulum and mitochondria.
The current study further shows that the T3-induced phosphorylation of AMPK leads to increased fatty acid oxidation, which would subsequently increase mitochondrial acetyl-CoA levels and stimulate oxidative phosphorylation. T3 exerts profound effects on cell growth, differentiation, and thermogenesis, processes that may consume a considerable amount of ATP or dissipate mitochondrial membrane potential. Thus, cells with limited energy turnover could not properly respond to T3. The activation of AMPK would allow cells to switch on ATP-generating pathways and render them acceptable for T3.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1 (N2aTR
) were a generous gift from Professor J. Bernal (Instituto de Investigaciones Biomedicas, Madrid, Spain) (32). Neuro 2a cells stably transfected with human TRβ1 (N2aTRβ) were a generous gift from Professor J. Puymirat (Human Genetics Research Unit, Laval University, Quebec, Canada) (33). Differentiation of C2C12 cells into myotubes was induced by mitogen withdrawal (DMEM with 2% horse serum) and was confirmed by troponin T expression. The differentiation of 3T3-L1 cells into adipocytes was induced by combined treatment of the cells with 3-isobutyl-1-methylxanthine, dexamethasone, and insulin (34). Near-confluent cells were cultured in serum-deprived media for 12 h and treated with various hormones and reagents such as T3, oligomycin, ionomycin, STO-609, BAPTA-acetoxymethyl ester (BAPTA-AM), IP3, and 2APB, alone or in combination. These reagents were purchased from Sigma-Aldrich (St. Louis, MO), except for BAPTA-AM and IP3 (Dojindo Laboratories, Kumamoto, Japan).
Western Blot Analysis
The procedures used for preparation of whole-cell lysates and Western blot analysis were described in our previous report (22). In brief, whole-cell lysates (40 µg/lane) were separated by SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Amersham Pharmacia, Piscataway, NJ). The blots were probed with the first antibodies described below, followed by incubation with horseradish peroxidase-conjugated antirabbit IgG antibody. Rabbit anti-phospho-AMPK
-subunit (Thr-172), anti-AMPK
-subunit, and anti-phospho-ACC (Ser-79) antibodies were purchased from Cell Signaling (Beverly, MA). Rabbit anti-actin antibody was purchased from Sigma-Aldrich. Proteins were visualized using enhanced chemiluminescence (ECL) reagents (Pierce, Rockford, IL). Images of the membranes were obtained using an LAS-1000 lumino-image analyzer (Fuji Film, Tokyo, Japan), and densitometric analysis was performed using software on the LAS-1000 system.
Immunocytochemical Analysis
The procedures used for immunocytochemical analysis were described in our previous report (35). After fixation and blocking, cells were incubated with anti-phospho-AMPK (Thr-172) antibody followed by incubation with antirabbit IgG antibody conjugated to Alexa Fluor 488 (Molecular Probes, Eugene, OR). Counterstaining was performed using propidium iodide. Images were obtained using a confocal laser microscope (LSM510; Carl Zeiss, Jena, Germany) with the same set of optical parameters as described previously (36). Several images were captured, and densitometric analysis of the amounts of phosphorylated AMPK was performed using Multi Gauge software on the LAS-1000 system. Merged images were obtained using Adobe Photoshop software (version 7.0.1; Adobe Systems, San Jose, CA).
RT-PCR
The expression of LKB1, CaMKKβ, TR
, and TRβ1 was examined by RT-PCR using total RNA. The primer sequences are as follows: sense and antisense primers for LKB1, 5'-CTCATCGGCAAGTACCTGATG-3' and 5'- TGGGAAACGCTTCTCCGGCAC-3'; primers for mouse CaMKK-β, 5'- TAGAGTACTTGCATTACCAGAAGA-3' and 5'- TGGGTTTTTGTCCAACATCCGGGT-3'; primers for human CaMKK-β, 5'- TCGAGTACTTGCACTGCCAGAAGATC-3' and 5'-GGGGTTCTTGTCCAGCATACGGGT-3'; primers for human CaMKK-
, 5'-TCGAGTACTTGCACTGCCAGAAGATC-3' and 5'-GGGATTCTTGTCTAACATCTTCAG-3'; primers for TR
, 5'-AAGCCAAGCAAGGTGGAGTGT-3' and 5'-ATGCACTTCTTGAAGCGGCACA-3'; primers for chicken TR
, 5'-GGTCGTGTCTGATGCCATCT-3' and 5'- CTCCTGGTCCTCGAAGACCT-3'; primers for human TRβ1, 5'-GCTATGACCCAGAAAGTGAG-3' and 5'-TGTCACCTTCATCAGGAGTT-3'; primers for mouse and rat TRβ1, 5'-ACAGAAAATGGCCTTCCAGC-3' and 5'-TCTTGCTGTCATCCAGCACCA-3'; and primers for GAPDH (glyceraldehyde-3-phosphate dehydrogenase), 5'-GCACCGTCAAGGCTGAGAAC-3' and 5'-GCCTTCTCCATGGTGGTGAA-3'.
siRNA
A predesigned siRNA directed against CaMKKβ (ID 110916, β3) and Silencer Negative Control no. 1 (nontargeting siRNA) were purchased from Ambion (Austin, TX). HeLa cells were seeded in six-well plates 24 h before transfection. siRNA (final concentration 80 nM) was introduced into cells using siPORT Lipid (Ambion).
Measurement of Intracellular Ca2+ Levels
Intracellular Ca2+ changes were measured using a fluorescent dye technique. The detailed procedures were described in our previous report (37). In brief, HeLa cells cultured on glass coverslips were treated for 45 min with 5 µM Fluo-4-AM (Molecular Probes), 0.02% pluronic acid F127 (Molecular Probes), and 1.25 mM probenecid in HEPES-buffered Ringer solution. In some experiments, cells were preincubated with 10 µM BAPTA-AM for 15 min; then, 5 µM Fluo-4 was added and incubated for 45 min. The coverslips were placed in a chamber mounted on the stage of an inverted microscope (Axiovert, Zeiss) equipped with a confocal laser scanning system (Oz; Noran, Middleton, WT) and then superfused with HEPES-buffered Ringer solution at a flow rate of 3 ml/min. Five consecutive images with 6-sec intervals were obtained before T3 stimulation. The cells were then treated with 10 nM T3 for 180 sec, and 45 consecutive images were obtained during and after T3 treatment for 270 sec. The averages of all the fluorescence intensities of individual cells were analyzed using the Intervision 2D program (Noran).
A ratiometric calcium indicator, Indo-1-AM (Dojindo), was also used instead of Fluo-4-AM. When Indo-1 binds Ca2+, the fluorescence emission at 405 nm increases, and the emission at 495 nm decreases. Measurement of the ratio of these emission intensities allows accurate estimation of intracellular Ca2+ concentrations, independent of intracellular dye concentrations. Indo-1-AM was loaded using the same protocol as Fluo-4-AM. To prevent photodegradation of Indo-1, 10 mM Trolox (EMD Biosciences, La Jolla, CA) was added to HEPES-Ringer. Indo-1 was excited at 351 nm. The emissions at 400–445 nm (FS) and longer than 445 nm (FL) were captured simultaneously using a dichroic mirror (445 nm) and a 400-nm longpass barrier filter, and the Indo-1 ratios (the ratio of FS to FL) in individual cells were calculated.
Measurement of Fatty Acid Oxidation
Fatty acid oxidation was determined using [9,10(n)-3H]palmitic acid (GE Healthcare Amersham, Buckinghamshire, UK). Palmitic acids were conjugated to fatty acid-free BSA (Sigma-Aldrich) by incubating DMEM containing 2% fatty acid-free BSA, 0.3 mM palmitic acid (Sigma-Aldrich), and 1 µCi/ml [3H]palmitic acid at 45 C. HeLa cells seeded in six-well plates on the day before the experiment were preincubated for 2 h in DMEM containing 0.5% fatty acid-free BSA. Then they were incubated for 3 h in DMEM containing [3H]palmitic acids conjugated to BSA in the presence or absence of 10 nM T3, 10 µM BAPTA, and 1 µM STO-609. After incubation, the media were collected, and the labeled palmitic acids remaining in the media were removed by precipitation with perchloric acid. Precipitation was performed twice. The radioactivity of the supernatants was determined using a liquid scintillation counter to quantify the radioactive water production.
Statistical Analysis
Statistical analysis was performed using ANOVA followed by Bonferronis multiple t test; a P value < 0.05 was considered to be statistically significant.
| FOOTNOTES |
|---|
Disclosure Statement: The authors have nothing to disclose.
First Published Online January 10, 2008
Abbreviations: ACC, Acetyl-coenzyme A carboxylase; AM, acetoxymethyl ester; AMPK, AMP-activated protein kinase; 2APB, 2-aminoethoxydiphenyl borate; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; CaMKKβ, Ca2+/calmodulin-dependent protein kinase kinase-β; CoA, coenzyme A; IP3, inositol 1,4,5-triphosphate; TH, thyroid hormone; TR, T3 receptor.
Received for publication May 10, 2007. Accepted for publication January 2, 2008.
| REFERENCES |
|---|
|
|
|---|
AMPK pathway. Curr Opin Cell Biol 17:167–173[CrossRef][Medline]NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
L. Zhou, S. S. Deepa, J. C. Etzler, J. Ryu, X. Mao, Q. Fang, D. D. Liu, J. M. Torres, W. Jia, J. D. Lechleiter, et al. Adiponectin Activates AMP-activated Protein Kinase in Muscle Cells via APPL1/LKB1-dependent and Phospholipase C/Ca2+/Ca2+/Calmodulin-dependent Protein Kinase Kinase-dependent Pathways J. Biol. Chem., August 14, 2009; 284(33): 22426 - 22435. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Means Commentary: The Year in Basic Science: Calmodulin Kinase Cascades Mol. Endocrinol., December 1, 2008; 22(12): 2759 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Lange, R. Senese, F. Cioffi, M. Moreno, A. Lombardi, E. Silvestri, F. Goglia, and A. Lanni Rapid Activation by 3,5,3'-L-Triiodothyronine of Adenosine 5'-Monophosphate-Activated Protein Kinase/Acetyl-Coenzyme A Carboxylase and Akt/Protein Kinase B Signaling Pathways: Relation to Changes in Fuel Metabolism and Myosin Heavy-Chain Protein Content in Rat Gastrocnemius Muscle in Vivo Endocrinology, December 1, 2008; 149(12): 6462 - 6470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W.-m. Chu, K.-l. Guan, and Y. Wan AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes J. Biol. Chem., October 24, 2008; 283(43): 28897 - 28908. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |